ACT 2 PROJ 2 LONGEVITY FOODS AND OBESITY-ASSOCIATED INSULIN RESISTANCE

行动 2 项目 2 长寿食品和肥胖相关的胰岛素抵抗

基本信息

  • 批准号:
    7959178
  • 负责人:
  • 金额:
    $ 12.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Obesity has reached epidemic proportions in the United States and is closely linked to type 2 diabetes and cardiovascular disease (CVD), leading the Surgeon General to issue a call for a national effort not only to identify the causes of obesity, but also to outline effective and culturally appropriate interventions. Efficacies of current therapies for obesity are complicated due to inability to maintain long-term weight loss, while those for type 2 diabetes are prone to drug-drug interactions and various side effects, such as additional weight gain and secondary failure. Interestingly, the occurrence of chronic diseases, such as diabetes and heart disease, among Okinawan Japanese is only one fifth that of Americans. Among the various lifestyle factors are lower calorie intake and high consumption of fruits and vegetables. The long-term goal of this research is to investigate the efficacy of medicinal/functional foods to prevent and/or ameliorate obesity-associated insulin resistance, diabetic dyslipidemia and CVDs, and to identify the underlying mechanisms. This project aims to identify specific molecular targets and delineate the mechanisms involved in ameliorating obesity-associated insulin resistance, using Momordica charantia (bitter melon, BM), an Asian vegetable. The specific aim of the project in year three was to investigate Sirt-PPARgamma-NCoR interactions in adipocytes. We expect to translate the results of the in vitro and in vivo studies to clinical trials among minority populations with obesity and/or type 2 diabetes mellitus. Such studies may have a significant impact on the development of therapeutic regimens that can be incorporated into the daily diet.
该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金, 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说,它不一定是研究者的机构。 肥胖在美国已达到流行病的程度,并且与 2 型糖尿病和心血管疾病 (CVD) 密切相关,因此美国卫生局局长呼吁全国不仅要努力查明肥胖的原因,还要制定有效且适合文化的干预措施。由于无法维持长期体重减轻,目前治疗肥胖症的疗法的疗效很复杂,而治疗 2 型糖尿病的疗法则容易出现药物间相互作用和各种副作用,例如体重额外增加和继发性失败。有趣的是,冲绳日本人患糖尿病、心脏病等慢性病的比例仅为美国人的五分之一。各种生活方式因素包括较低的热量摄入和大量的水果和蔬菜消耗。这项研究的长期目标是调查药用/功能性食品预防和/或改善肥胖相关的胰岛素抵抗、糖尿病血脂异常和心血管疾病的功效,并确定其潜在机制。该项目旨在利用亚洲蔬菜苦瓜(苦瓜,BM)来确定特定的分子靶点并描述改善肥胖相关胰岛素抵抗的机制。第三年该项目的具体目标是研究脂肪细胞中的 Sirt-PPARgamma-NCoR 相互作用。 我们期望将体外和体内研究的结果转化为针对少数肥胖和/或 2 型糖尿病人群的临床试验。此类研究可能会对可纳入日常饮食的治疗方案的开发产生重大影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pratibha V Nerurkar其他文献

Erratum to: strategies to improve palatability and increase consumption intentions for Momordica charantia(bitter melon): a vegetable commonly used for diabetes management
  • DOI:
    10.1186/1475-2891-13-3
  • 发表时间:
    2014-01-10
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Laura S Snee;Vivek R Nerurkar;Dian A Dooley;Jimmy T Efird;Anne C Shovic;Pratibha V Nerurkar
  • 通讯作者:
    Pratibha V Nerurkar

Pratibha V Nerurkar的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Pratibha V Nerurkar', 18)}}的其他基金

ACT 2 PROJ 2: LONGEVITY FOODS AND OBESITY-ASSOCIATED INSULIN RESISTANCE
第 2 步项目 2:长寿食品和肥胖相关的胰岛素抵抗
  • 批准号:
    7715309
  • 财政年份:
    2008
  • 资助金额:
    $ 12.36万
  • 项目类别:
ACT 2 PROJ 2: LONGEVITY FOODS AND OBESITY-ASSOCIATED INSULIN RESISTANCE
第 2 步项目 2:长寿食品和肥胖相关的胰岛素抵抗
  • 批准号:
    7561550
  • 财政年份:
    2007
  • 资助金额:
    $ 12.36万
  • 项目类别:
Longevity foods, SIRT activation and diabetic dyslipidemia.
长寿食品、SIRT 激活和糖尿病血脂异常。
  • 批准号:
    7318726
  • 财政年份:
    2007
  • 资助金额:
    $ 12.36万
  • 项目类别:
Longevity foods, SIRT activation and diabetic dyslipidemia.
长寿食品、SIRT 激活和糖尿病血脂异常。
  • 批准号:
    7501261
  • 财政年份:
    2007
  • 资助金额:
    $ 12.36万
  • 项目类别:
IN UTERO EXPOSURE TO HAART
子宫内暴露于 HAART
  • 批准号:
    7380982
  • 财政年份:
    2006
  • 资助金额:
    $ 12.36万
  • 项目类别:
ROLE OF UP-2 & ATP SYNTHESIS IN PATHOGENESIS OF NRTI-ASSOCIATED LACTIC ACIDOSIS
UP-2 的作用
  • 批准号:
    7169010
  • 财政年份:
    2005
  • 资助金额:
    $ 12.36万
  • 项目类别:
ROLE OF UP-2 & ATP SYNTHESIS IN PATHOGENESIS OF NRTI-ASSOCIATED LACTIC ACIDOSIS
UP-2 的作用
  • 批准号:
    7011547
  • 财政年份:
    2004
  • 资助金额:
    $ 12.36万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 12.36万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 12.36万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了